Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
is the capital and most populous city in the State of Indiana. It is growing economically thanks to a strong corporate base anchored by the life sciences. Indiana is home to one of the largest
-
, and high-throughput screening will support an ambitious drug discovery program. Applicants should hold a PhD (or equivalent) in medicinal chemistry, organic chemistry, chemical biology, or a closely
-
chemical transformations. Motivated applicants with PhD training in any area of chemistry or biochemistry will be considered. Experience with either molecular biology or synthetic chemistry is strongly
-
is the capital and most populous city in the State of Indiana. It is growing economically thanks to a strong corporate base anchored by the life sciences. Indiana is home to one of the largest
-
institutional budget dollars are fully set aside and carved out specifically for this Director to scale, recruit, and custom-build their program from day one. Enhance Clinical Care Delivery System-Wide: Enhance
-
technologies, platforms, and strategies. Develop and maintain a productive scholarly program in areas such as microbiology, infectious diseases, diagnostic innovation, antimicrobial resistance, or host–pathogen
-
information on life in Indy: https://faculty.medicine.iu.edu/relocation Basic Qualifications Education: PhD in Pharmacology, Pharmaceutical Sciences, Toxicology, or a related field. Department Contact
-
for candidates interested in pursuing independent academic careers, research scientist positions, or leadership roles in human genetics, statistical genetics, computational biology, data science, or industry
-
candidate will have an independent laboratory program focused on GU cancer biology, drug development, biomarkers, mechanisms of resistance, tumor microenvironment, immuno-oncology, radiopharmaceuticals
-
recruiting a Board-certified/Board Eligible M.D., or MD/PhD, or PhD for a Clinical Laboratory Director role in the Division of Diagnostic Genomics and Therapeutics. We are soliciting applications from